Loading...
CTRE logo

CareTrust REIT, Inc.NYSE:CTRE Aktienübersicht

Marktkapitalisierung US$9.4b
Aktienkurs
n/a
1Y15.1%
7D2.4%
1D-0.2%
Wert des Portfolios
Siehe

CareTrust REIT, Inc.

NYSE:CTRE Lagerbericht

Marktkapitalisierung: US$9.4b

CareTrust REIT (CTRE) Aktienübersicht

CareTrust REIT, Inc. ist ein selbstverwalteter, börsennotierter Real Estate Investment Trust, der sich mit dem Besitz, dem Erwerb, der Entwicklung und der Vermietung von Objekten für qualifizierte Pflege, Seniorenwohnungen und anderen Objekten im Gesundheitswesen beschäftigt. Mehr Details

CTRE grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung4/6
Künftiges Wachstum3/6
Vergangene Leistung5/6
Finanzielle Gesundheit5/6
Dividenden4/6

CTRE Community Fair Values

Create Narrative

See what 110 others think this stock is worth. Follow their fair value or set your own to get alerts.

CareTrust REIT, Inc. Wettbewerber

Preisentwicklung & Leistung

Zusammenfassung der Höchst- und Tiefststände sowie der Veränderungen der Aktienkurse für CareTrust REIT
Historische Aktienkurse
Aktueller AktienkursUS$39.76
52-Wochen-HochUS$43.62
52-Wochen-TiefUS$32.79
Beta0.80
1 Monat Veränderung-8.39%
3 Monate Veränderung-3.35%
1 Jahr Veränderung15.11%
3 Jahre Veränderung101.42%
5 Jahre Veränderung85.79%
Veränderung seit IPO127.33%

Aktuelle Nachrichten und Updates

Seeking Alpha Aug 18

CareTrust: Buy The Dip On This Income And Growth Machine

Summary CareTrust REIT is upgraded to 'Buy' after a price pullback, offering a rare blend of yield and high growth. CTRE's diversified platform, robust pipeline, and focus on quality operators underpin 16% FFO/share growth guidance for 2026. A strong balance sheet and 4% yield support continued dividend growth and total return potential. Despite trading at an 18.95x forward P/FFO premium, demographic tailwinds and disciplined acquisitions justify expectations for double-digit annualized returns. Read the full article on Seeking Alpha

Recent updates

Seeking Alpha Aug 18

CareTrust: Buy The Dip On This Income And Growth Machine

Summary CareTrust REIT is upgraded to 'Buy' after a price pullback, offering a rare blend of yield and high growth. CTRE's diversified platform, robust pipeline, and focus on quality operators underpin 16% FFO/share growth guidance for 2026. A strong balance sheet and 4% yield support continued dividend growth and total return potential. Despite trading at an 18.95x forward P/FFO premium, demographic tailwinds and disciplined acquisitions justify expectations for double-digit annualized returns. Read the full article on Seeking Alpha
Narrative-Update Jun 16

CTRE: Acquisition Pipeline And Raised Guidance Will Support Future Share Upside

Analysts have lifted the CareTrust REIT price target by about $0.60 to $45.50, citing updated models that factor in recent Q1 healthcare REIT research and a refined view on revenue growth, margins, and future P/E assumptions, supported by higher Street targets from firms such as KeyBanc, BofA, and Wells Fargo. Analyst Commentary Recent Street research on CareTrust REIT highlights a generally constructive tone around the stock, with several firms revisiting their models after Q1 healthcare REIT updates and adjusting price targets accordingly.
Narrative-Update Jun 01

CTRE: Forward Equity And Pipeline Deployment Will Drive Future Upside Potential

The updated analyst price target for CareTrust REIT edges up from about $43.67 to $44.91 per share, supported by recent Street revisions that lifted individual targets to $46 and $49 as analysts refreshed their models following Q1 healthcare REIT earnings and reaffirmed positive views on the stock. Analyst Commentary Recent Street commentary on CareTrust REIT has skewed constructive, with several bullish analysts lifting price targets after updating models around Q1 healthcare REIT earnings and reiterating positive stances on the stock.
Narrative-Update May 15

CTRE: Future Returns Will Reflect Accretive Pipeline And Execution On 2026 Plans

Analysts have nudged their average price target on CareTrust REIT to about $43.67, with recent research pointing to modestly higher expected profitability and updated assumptions for growth, capital deployment and valuation. Analyst Commentary Recent research on CareTrust REIT clusters around a similar message, with several firms adjusting price targets and updating models after the latest Q4 results and 2026 guidance.
Narrative-Update Apr 23

CTRE: Future Returns Will Reflect Accretive Pipeline And Aging Demographic Demand

The updated analyst price target for CareTrust REIT edges slightly lower to about $43.67 from $43.75, as analysts factor in modest adjustments to the discount rate and forward P/E, while maintaining generally supportive views on capital deployment and recent research upgrades. Analyst Commentary Bullish Takeaways Bullish analysts highlight CareTrust REIT's three operating platforms as a key driver for deploying capital accretively, which they see as supportive for the current valuation framework.
Narrative-Update Apr 09

CTRE: Future Returns Will Reflect Accretive Acquisitions Supported By Aging Demographic Demand

Analysts have slightly trimmed the CareTrust REIT fair value estimate to about $43.75, while still citing supportive views on capital deployment, acquisition-driven growth and aging demographic demand, as reflected in a series of recent price target increases across the Street. Analyst Commentary Recent Street research around CareTrust REIT has clustered around higher price targets and generally supportive commentary on the business model, with a few valuation and execution watchpoints that readers should keep in mind.
Narrative-Update Mar 26

CTRE: Future Returns Will Reflect Accretive Capital Deployment Across Three Platforms

Narrative Update Analysts have raised their average price target for CareTrust REIT to a range of $44 to $46, citing the company’s capacity to deploy capital across its platforms and expectations that recent FFO guidance adjustments and investment timing shifts can be absorbed over time. Analyst Commentary Recent research points to a generally constructive view on CareTrust REIT, with multiple firms lifting price targets and a mix of optimism on growth against some questions on guidance and expenses.
Narrative-Update Mar 11

CTRE: Future Returns Will Reflect Accretive Platforms And Tight Senior Care Supply

The analyst price target for CareTrust REIT has edged up by about $0.27 as analysts factor in updated Q4 results, modestly lower discount rate assumptions, and ongoing opportunities to deploy capital across its operating platforms. Analyst Commentary Recent Street research on CareTrust REIT reflects a generally constructive tone, with several firms lifting their price targets following the latest Q4 update and refreshed 2026 guidance.
Narrative-Update Feb 25

CTRE: Future Returns Will Reflect Accretive 2026 Acquisitions And Tight Senior Care Supply

Analysts lifted the CareTrust REIT fair value estimate from $41.45 to $43.55 after a series of higher price targets in the $42 to $46 range. They pointed to updated FFO timing, acquisition opportunities across its operating platforms, and refreshed 2026 outlooks as key supports for the new target.
Narrative-Update Feb 09

CTRE: Future Returns Will Reflect Accretive Acquisitions And Tight Senior Care Supply

Narrative Update on CareTrust REIT The updated analyst price target for CareTrust REIT edges higher from US$41.36 to US$41.45, with analysts pointing to accretive acquisition activity, skilled nursing exposure, and supportive sector supply and demand as key drivers behind the refined fair value and P/E assumptions. Analyst Commentary Recent research updates on CareTrust REIT focus on its acquisition pipeline, exposure to skilled nursing facilities, and the supply backdrop in its core markets.
Narrative-Update Jan 25

CTRE: Future Returns Will Reflect Accretive Acquisitions And Skilled Nursing Demand

Analysts have lifted their CareTrust REIT fair value estimate from about US$40.70 to roughly US$41.36, citing more constructive views on future investment volumes, rent coverage, and acquisition driven growth. Analyst Commentary Bullish analysts have been revisiting their views on CareTrust REIT, with several recent research notes focusing on its acquisition pipeline, rent coverage, and exposure to senior care demand drivers.
Narrative-Update Jan 10

CTRE: Future Returns Will Balance Skilled Nursing Exposure And Accretive Acquisition Opportunities

Narrative Update The analyst price target for CareTrust REIT has moved modestly higher to about US$40.70. Analysts point to accretive acquisitions in a tight supply setting, aging demographics, and expectations for better investment volumes and rent coverage as key supports for their updated view.
Narrative-Update Dec 15

CTRE: Future Returns Will Reflect Skilled Nursing Strength And Rising Investment Volumes

Analysts have raised their price target on CareTrust REIT from $39.55 to $40.64 per share, citing expectations for stronger investment volumes, improving rent coverage, and slightly better long term growth and profitability assumptions. Analyst Commentary Recent research updates emphasize that bullish analysts see the revised price target as supported by both operational momentum and a robust external growth pipeline.
Narrative-Update Dec 01

CTRE: Future Performance Will Reflect Skilled Nursing Exposure And International Expansion

Analysts have raised their price target for CareTrust REIT from $38.44 to $39.55, citing anticipated positive estimate revisions due to stronger investment volumes and robust rent coverage in skilled nursing facilities. Analyst Commentary Recent analyst coverage has focused on CareTrust REIT's outlook and valuation following its adjusted price target.
Narrative-Update Nov 17

CTRE: Future Expansion and Leadership Transition Will Shape International Outlook

Analysts have slightly raised their price target for CareTrust REIT from $37.89 to $38.44. This reflects updated forecasts that balance a modestly lower expected revenue growth and profit margin with a reduced discount rate and increased projected future valuation.
Narrative-Update Nov 03

CTRE: Capital Raise And UK Acquisition Will Drive Balanced Future Performance

Analysts have raised their price target for CareTrust REIT to $36, up from previous estimates by as much as $4. They cite strong capital deployment and the company's significant investment pipeline following its recent share issuance.
Narrative-Update Oct 20

UK Care Home Entry And Diversification Will Secure Enduring Potential

CareTrust REIT’s analyst price target has increased modestly from $37.56 to $37.89. Analysts cite the company’s enlarged equity raise and active investment pipeline as supportive factors for improved valuations.
Narrative-Update Oct 05

UK Care Home Entry And Diversification Will Secure Enduring Potential

Analysts have increased their price target for CareTrust REIT to $37.56 from $36.89. They cite a robust investment pipeline, improved profit margins, and strong capital deployment as key supporting factors for the positive outlook.
Narrative-Update Sep 04

UK Care Home Entry And Diversification Will Secure Enduring Potential

The consensus analyst price target for CareTrust REIT was maintained at $36.89, as analysts cite the successful equity offering and strengthened balance sheet as supporting a robust investment pipeline and near-term growth. Analyst Commentary Upsized follow-on equity offering generating $736M in gross proceeds, providing significant funding.
Narrative-Update Aug 20

UK Care Home Entry And Diversification Will Secure Enduring Potential

CareTrust REIT’s consensus price target was raised to $35.33 as analysts anticipate enhanced growth and financial flexibility following a successful capital raise, robust investment pipeline, and strengthened balance sheet. Analyst Commentary Successful completion of a 20M share upsized issuance, providing gross proceeds up to $736M, which increases liquidity and funds investment opportunities.
Seeking Alpha Mar 17

CareTrust REIT: Buy This Ship Before It Sails (Rating Upgrade)

Summary CareTrust REIT, Inc. has shown strong financial performance with robust FFO growth and significant acquisitions, enhancing its investment appeal. CTRE's robust balance sheet, with ultra-low net debt-to-EBITDA of 0.5x and ample liquidity, supports its aggressive acquisition strategy and dividend growth. Favorable policy expectations and high-quality operators position CTRE well for continued expansion, justifying an upgrade from Hold to Buy. Read the full article on Seeking Alpha
Seeking Alpha Feb 25

CareTrust REIT: Expected Double-Digit Growth And Recent Pullback Make This Stock A Long-Term Buy

Summary CareTrust REIT's strong balance sheet and double-digit FFO growth in a challenging economy make it a compelling buy for long-term investors. The REIT's impressive acquisition spree and robust pipeline position it for continued growth, despite macroeconomic uncertainties and high interest rates. With no debt maturing for the next 3 years and a well-covered dividend yield over 4%, CTRE offers significant upside potential. Current valuation remains attractive, and management's guidance for 2025 suggests further double-digit growth, making CTRE an ideal long-term investment. Read the full article on Seeking Alpha
Seeking Alpha Jan 16

CareTrust REIT: A Growth And Cashflow Engine Serving A Vital Society Need

Summary In my initial coverage of CareTrust REIT, I'm calling it a buy, agreeing with the bullish sentiment from analysts and the quant system. Macro factors point to continued demand growth for senior living and skilled nursing facilities. This REIT keeps growing its property portfolio, though much of it so far has been concentrated in Texas and California. CTRE stock's profit margin beats similar peers, and it has a proven positive cashflow, increasing the likelihood the dividend will be supported. This REIT has the lowest debt/equity among the peer group selected, and stable/positive credit ratings from major agencies. Read the full article on Seeking Alpha
Seeking Alpha Dec 18

CareTrust REIT: An Acquisition Titan That's Still A Buy For Long-Term Investors

Summary CareTrust REIT remains a buy due to strong fundamentals, impressive acquisitions, and a recent price pullback, offering long-term growth potential. The REIT's acquisition spree, totaling nearly $1 billion in 2023, has significantly boosted FFO and revenue, showcasing robust growth despite economic challenges. CareTrust's fortress balance sheet, low leverage, and potential credit rating upgrade position it for further upside and acquisition opportunities. Risks include high tenant exposure to The Ensign Group and significant property concentration in California, but the overall outlook remains positive for long-term investors. Read the full article on Seeking Alpha
Seeking Alpha Dec 04

CareTrust REIT: Strong Fundamentals And Growth Potential - Buy

Summary I rate CareTrust REIT a buy due to its strong fundamentals, consistent financial performance, and promising growth prospects driven by acquisitions and demographic trends. CTRE's financials are impressive, with consistent revenue growth, stable operating expenses, and a strong balance sheet, justifying its premium valuation. The company's robust market position, diversified portfolio, and extensive geographical presence provide stability and growth opportunities, particularly in high-demand states like California and Texas. Despite trading at a premium, CTRE's growth potential, solid financial footing, and strategic acquisitions make it a compelling investment opportunity in the healthcare REIT sector. Read the full article on Seeking Alpha

Aktionärsrenditen

CTREUS Health Care REITsUS Markt
7D2.4%2.6%-0.8%
1Y15.1%29.6%20.5%

Rendite im Vergleich zur Industrie: CTRE unter dem Niveau der Branche US Health Care REITs , die im vergangenen Jahr eine Rendite von 29.6% erzielte.

Rendite vs. Markt: CTRE hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 20.5 erzielte.

Preisvolatilität

Is CTRE's price volatile compared to industry and market?
CTRE volatility
CTRE Average Weekly Movement3.8%
Health Care REITs Industry Average Movement4.1%
Market Average Movement7.2%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market3.1%

Stabiler Aktienkurs: CTRE hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.

Volatilität im Zeitverlauf: CTREDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
201343Dave Sedgwickwww.caretrustreit.com

CareTrust REIT, Inc. ist ein selbstverwalteter, börsennotierter Immobilieninvestmentfonds, der sich mit dem Besitz, dem Erwerb, der Entwicklung und der Vermietung von Einrichtungen für die qualifizierte Pflege, Seniorenwohnungen und anderen gesundheitsbezogenen Immobilien befasst. Mit einem Portfolio aus langfristig nettovermieteten Immobilien in den Vereinigten Staaten und im Vereinigten Königreich sowie einem wachsenden Bestand an hochwertigen Betreibern, die diese Immobilien pachten, verfolgt CareTrust sowohl externe als auch organische Wachstumschancen in den USA und auf internationaler Ebene. CareTrust REIT, Inc. wurde 2013 gegründet und ist in Maryland eingetragen.

CareTrust REIT, Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von CareTrust REIT im Vergleich zum Marktanteil des Unternehmens?
CTRE grundlegende Statistiken
MarktanteilUS$9.41b
Gewinn(TTM)US$355.56m
Umsatz(TTM)US$571.43m
26.4x
Kurs-Gewinn-Verhältnis
16.4x
Kurs-Umsatz-Verhältnis

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
CTRE Gewinn- und Verlustrechnung (TTM)
EinnahmenUS$571.43m
Kosten der EinnahmenUS$20.77m
BruttogewinnUS$550.66m
Sonstige AusgabenUS$195.10m
GewinnUS$355.56m

Zuletzt gemeldete Gewinne

Jun 30, 2026

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)1.50
Bruttomarge96.36%
Nettogewinnspanne62.22%
Schulden/Eigenkapital-Verhältnis26.7%

Wie hat sich CTRE auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

3.9%
Aktuelle Dividendenrendite
-423%
Ausschüttungsquote

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/08/20 21:39
Aktienkurs zum Tagesende2026/08/20 00:00
Gewinne2026/06/30
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

CareTrust REIT, Inc. wird von 26 Analysten beobachtet. 5 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
David RodgersBaird
Amanda SweitzerBaird
Steven ValiquetteBarclays